{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:17:01Z","timestamp":1791083821642,"version":"4.1.0"},"reference-count":31,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Since the start of the SARS-CoV-2 pandemic, several treatments have been proposed to prevent the progression of the disease. Currently, three antiviral (molnupiravir, nirmaltrevir\/r, remdesivir) and two monoclonal antibodies (casirivimab\/imdevimab and sotrovimab) are available in Italy. Therefore, we aimed to evaluate the presence of risk factors associated with disease progression. We conducted a retrospective cohort study, including all patients with a confirmed diagnosis of SARS-CoV-2 evaluated between 01\/01\/2022 ad 10\/05\/2022 by our Unit of Infectious Diseases in Sassari. We defined disease progression as the necessity of starting O2 therapy. According to AIFA (Italian Medicines Agency) indications, preventive treatment was prescribed in patients with recent symptoms onset (\u2264five days), no need for oxygen supplementation, and risk factors for disease progression. Subgroup differences in quantitative variables were evaluated using Student\u2019s t-test. Pearson chi-square or Fisher\u2019s exact tests were used to assess differences for qualitative variables. Multivariate logistic regression modelling was performed to determine factors associated with progression. A two-tailed p-value less than 0.05 was considered statistically significant. All statistical analyses were performed with STATA version 17 (StataCorp, College Station, TX, USA). We included 1145 people with SARS-CoV-2 diagnosis, of which 336 (29.3%) developed severe disease with oxygen supplementation. In multivariate logistic regression analysis, age, dementia, haematologic tumors, heart failure, dyspnoea or fever at first evaluation, having ground glass opacities or consolidation at the first CT scan, and bacteria coinfection were associated with an increased risk of disease progression. Vaccination (at least two doses) and early treatment with antiviral or monoclonal antibodies were associated with a lower risk of disease progression. In conclusion, our study showed that vaccination and early treatment with antiviral and\/or monoclonal antibodies significantly reduce the risk of disease progression.<\/jats:p>","DOI":"10.3390\/v15010071","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T07:30:06Z","timestamp":1672126206000},"page":"71","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8265-5400","authenticated-orcid":false,"given":"Andrea","family":"De Vito","sequence":"first","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Colpani","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-9367","authenticated-orcid":false,"given":"Laura","family":"Saderi","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Medical Statistics Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5656-6845","authenticated-orcid":false,"given":"Mariangela","family":"Puci","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3358-5936","authenticated-orcid":false,"given":"Beatrice","family":"Zauli","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Fiore","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fois","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Meloni","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bitti","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Di Castri","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Maida","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7291-8687","authenticated-orcid":false,"given":"Sergio","family":"Babudieri","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1600-4474","authenticated-orcid":false,"given":"Giovanni","family":"Sotgiu","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Medical Statistics Unit, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6099-2273","authenticated-orcid":false,"given":"Giordano","family":"Madeddu","sequence":"additional","affiliation":[{"name":"Unit of Infectious Disease, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"key":"ref_1","unstructured":"Commission WMH (2020, March 01). Report of Clustering Pneumonia of Unknown Etiology in Wuhan City, Available online: http:\/\/wjw.wuhan.gov.cn\/front\/web\/showDetail\/2019123108989."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunologic features in severe and moderate Coronavirus Disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_4","unstructured":"WHO (2020, May 11). COVID-19 Weekly Epidemiological Ipdate. Available online: https:\/\/www.who.int\/publications\/m\/item\/covid-19-weekly-epidemiological-update."},{"key":"ref_5","first-page":"7861","article-title":"Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy","volume":"24","author":"Geremia","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1473-3099(20)30402-3","article-title":"Silent COVID-19: What your skin can reveal","volume":"21","author":"Guarneri","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/wound.2020.1309","article-title":"Cutaneous Manifestations of COVID-19: A Systematic Review","volume":"10","author":"Singh","year":"2021","journal-title":"Adv. Wound Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/IPC.0000000000000952","article-title":"A Case of Vasculitis-Like Skin Eruption Associated With COVID-19","volume":"28","author":"Geremia","year":"2020","journal-title":"Infect. Dis. Clin. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"De Vito, A., Fiore, V., Princic, E., Geremia, N., Panu Napodano, C.M., Muredda, A.A., Maida, I., Madeddu, G., and Babudieri, S. (2021). Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248009"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hed.26269","article-title":"Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study","volume":"42","author":"Vaira","year":"2020","journal-title":"Head Neck"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107228","DOI":"10.1016\/j.carpath.2020.107228","article-title":"Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019","volume":"47","author":"Geng","year":"2020","journal-title":"Cardiovasc. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12929-022-00853-8","article-title":"COVID-19 vaccine update: Vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection","volume":"29","author":"Chi","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","article-title":"The tangled history of mRNA vaccines","volume":"597","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_17","first-page":"1","article-title":"Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: A nested case-control study","volume":"38","author":"Poliseno","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jmv.26016","article-title":"use of subcutaneous tocilizumab in patients with COVID-19 pneumonia","volume":"93","author":"Mazzitelli","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_19","unstructured":"Vito, A.D., Saderi, L., Fiore, V., Geremia, N., Princic, E., Fanelli, C., Muredda, A.A., Napodano, C.P., Moi, G., and Maida, I. (2022). Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients. Panminerva Med., Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/35622392\/."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group, Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., Linsell, L., Staplin, N., Brightling, C., and Ustianowski, A. (2021). Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients","volume":"386","author":"Musungaie","year":"2022","journal-title":"New Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2204919","article-title":"Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge","volume":"387","author":"Arbel","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1002\/jmv.28011","article-title":"Safety and efficacy of molnupiravir in SARS-CoV-2 infected patients: A real-life experience","volume":"94","author":"Colpani","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S1473-3099(22)00507-2","article-title":"Real-world effectiveness of early molnupiravir or nirmatrelvir\u2013ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong\u2019s omicron BA.2 wave: A retrospective cohort study","volume":"22","author":"Wong","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Najjar-Debbiny, R., Gronich, N., Weber, G., Khoury, J., Amar, M., Stein, N., Goldstein, L.H., and Saliba, W. (2022, October 31). Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients. Clin. Infect. Dis., Available online: https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciac443\/6599020.","DOI":"10.1093\/cid\/ciac443"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Najjar-Debbiny, R., Gronich, N., Weber, G., Khoury, J., Amar, M., Stein, N., Goldstein, L.H., and Saliba, W. (2022, October 31). Effectiveness of Molnupiravir in High-Risk Patients: A Propensity Score Matched Analysis. Clin. Infect. Dis., Available online: https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciac781\/6708264.","DOI":"10.1093\/cid\/ciac781"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(22)01586-0","article-title":"Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: An observational study","volume":"400","author":"Wong","year":"2022","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Gentile, I., Scotto, R., Moriello, N.S., Pinchera, B., Villari, R., Trucillo, E., Ametrano, L., Fusco, L., Castaldo, G., and Buonomo, A.R. (2022). Nirmatrelvir\/Ritonavir and Molnupiravir in the Treatment of Mild\/Moderate COVID-19: Results of a Real-Life Study. Vaccines, 10.","DOI":"10.1101\/2022.08.23.22278585"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/jac\/dkac256","article-title":"Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge","volume":"77","author":"Piccicacco","year":"2022","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/1\/71\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:52:17Z","timestamp":1760147537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/15\/1\/71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["v15010071"],"URL":"https:\/\/doi.org\/10.3390\/v15010071","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,27]]}}}